SEARCH RESULTS

264915 RESULTS

LY3372689

THERAPEUTICS Small Molecule Tau Between February and June 2019, Lilly conducted Phase 1 safety testing of in LY3372689 in healthy adults. The crossover design evaluated two drug doses and placebo during three study periods in each of 23 participants. A total of six ...

Current Filters

  • Date Range : All x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE